...to identify and develop therapeutics against age-related disease targets in the brain. The deal combines Thuris's... ...Alzheimer's disease (AD) in animal brain tissue with Sigma-Tau's compounds. Sigma-Tau SpA , Rome, Italy Thuris Corp....
...will provide Thuris non-exclusive access to enzyme inhibitors that Thuris will evaluate in its assay. Thuris... ...products, and Thuris is eligible for milestones and royalties. Cephalon Inc. (CEPH), West Chester, Penn. Thuris Corp....
...to identify and develop therapeutics against age-related disease targets in the brain. The deal combines Thuris's... ...Alzheimer's disease (AD) in animal brain tissue with Sigma-Tau's compounds. Sigma-Tau SpA , Rome, Italy Thuris Corp....
...will provide Thuris non-exclusive access to enzyme inhibitors that Thuris will evaluate in its assay. Thuris... ...products, and Thuris is eligible for milestones and royalties. Cephalon Inc. (CEPH), West Chester, Penn. Thuris Corp....